PROSTATIC ADENOCARCINOMA

Clinical trials for PROSTATIC ADENOCARCINOMA explained in plain language.

Never miss a new study

Get alerted when new PROSTATIC ADENOCARCINOMA trials appear

Sign up with your email to follow new studies for PROSTATIC ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1 Not yet finished but already full! 1

New combo therapy aims to shrink aggressive prostate cancer before surgery

Disease control Ongoing

This study tests whether giving a mix of hormone-lowering medications (apalutamide, abiraterone, prednisone, and a GnRH drug) for a few months before surgery can shrink very high-risk prostate cancer and reduce the chance of it coming back. About 102 men with localized or low-vol…

Matched conditions: PROSTATIC ADENOCARCINOMA

Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control

Last updated Jun 27, 2026 12:24 UTC

PROSTATIC ADENOCARCINOMA

Get alerted when new PROSTATIC ADENOCARCINOMA trials appear

New combo therapy aims to shrink aggressive prostate cancer before surgery